Synergistic effect of EMF–BEMER-type pulsed weak electromagnetic field and HPMA-bound doxorubicin on mouse EL4 T-cell lymphoma

References

• Akan Z, Aksu B, Tulunay A, Bilsel S, Inhan-Garip A. (2010). Extremely low-frequency electromagnetic fields affect the immune response of monocyte-derived macrophages to pathogens. Bioelectromagnetics, 31, 603–612.
   PubMed Web of Science ®Google Scholar
• Arafa HM, Abd-Allah AR, El-Mahdy MA, Ramadan LA, Hamada FM. (2003). Immunomodulatory effects of L-carnitine and q10 in mouse spleen exposed to low-frequency high-intensity magnetic field. Toxicology, 187, 171–181.
   PubMed Web of Science ®Google Scholar
• Barbault A, Costa FP, Bottger B, Munden RF, Bomholt F, Kuster N, Pasche B. (2009). Amplitude-modulated electromagnetic fields for the treatment of cancer: Discovery of tumor-specific frequencies and assessment of a novel therapeutic approach. J Exp Clin Cancer Res, 28, 51.
   PubMed Web of Science ®Google Scholar
• Beneduci A, Chidichimo G, De Rose R, Filippelli L, Straface SV, Venuta S. (2005). Frequency and irradiation time-dependant antiproliferative effect of low-power millimeter waves on RPMI 7932 human melanoma cell line. Anticancer Res, 25, 1023–1028.
   PubMed Web of Science ®Google Scholar
• Beniashvili D, Avinoach’m I, Baasov D, Zusman I. (2005). The role of household electromagnetic fields in the development of mammary tumors in women: Clinical case-record observations. Med Sci Monit, 11, CR10–CR13.
   PubMed Web of Science ®Google Scholar
• Blank M, Goodman R. (1999). Electromagnetic fields may act directly on DNA. J Cell Biochem, 75, 369–374.
   PubMed Web of Science ®Google Scholar
• Boscolo P, Di Gioacchino M, Di Giampaolo L, Antonucci A, Di Luzio S. (2007). Combined effects of electromagnetic fields on immune and nervous responses. Int J Immunopathol Pharmacol, 20, 59–63.
   PubMedGoogle Scholar
• Busljeta I, Trosic I, Milkovic-Kraus S. (2004). Erythropoietic changes in rats after 2.45 GJz nonthermal irradiation. Int J Hyg Environ Health, 207, 549–554.
   PubMed Web of Science ®Google Scholar
• Cameron IL, Sun LZ, Short N, Hardman WE, Williams CD. (2005). Therapeutic Electromagnetic Field (TEMF) and gamma irradiation on human breast cancer xenograft growth, angiogenesis and metastasis. Cancer Cell Int, 5, 23.
   PubMed Web of Science ®Google Scholar
• de Vocht F. (2010). “Dirty electricity”: What, where, and should we care? J Expo Sci Environ Epidemiol, 20, 399–405.
   PubMed Web of Science ®Google Scholar
• Dressel R, Günther E. (1999). Heat-induced expression of MHC-linked HSP70 genes in lymphocytes varies at the single-cell level. J Cell Biochem, 72, 558–569.
   PubMed Web of Science ®Google Scholar
• Di Giampaolo L, Di Donato A, Antonucci A, Paiardini G, Travaglini P, Spagnoli G, Magrini A, Reale M, Dadorante V, Iannaccone U, Di Sciascio MB, Di Gioacchino M, Boscolo P. (2006). Follow up study on the immune response to low frequency electromagnetic fields in men and women working in a museum. Int J Immunopathol Pharmacol, 19, 37–42.
   PubMedGoogle Scholar
• Dunn GP, Old LJ, Schreiber RD. (2004). The immunobiology of cancer immunosurveillance and immunoediting. Immunity, 21, 137–148.
   PubMed Web of Science ®Google Scholar
• Erren TC. (2001). A meta-analysis of epidemiologic studies of electric and magnetic fields and breast cancer in women and men. Bioelectromagnetics, Suppl 5, S105–S119.
   Google Scholar
• Etrych T, Mrkvan T, Chytil P, Koňák Č, Říhová B, Ulbrich K. (2008). N-(2-hydroxypropyl)methacrylamide-based polymer conjugates with pH-controlled activation of doxorubicin. I. New synthesis, physicochemical characterization and preliminary biological evaluation. J Appl Polym Sci, 109, 3050–3061.
   Web of Science ®Google Scholar
• Forssén UM, Rutqvist LE, Ahlbom A, Feychting M. (2005). Occupational magnetic fields and female breast cancer: A case-control study using Swedish population registers and new exposure data. Am J Epidemiol, 161, 250–259.
   PubMed Web of Science ®Google Scholar
• Gabrys M. (2004). Pulsierende Magnetfeldtherapie bei zytostatisch bedingter Polyneuropathie. Deutsche Zeitschrift für Onkologie 3, 154–156.
   Google Scholar
• Gapeyev AB, Kulagina TP, Aripovsky AV, Chemeris NK. (2011). The role of fatty acids in anti-inflammatory effects of low-intensity extremely high-frequency electromagnetic radiation. Bioelectromagnetics, 32, 388–395.
   PubMed Web of Science ®Google Scholar
• Girgert R, Schimming H, Körner W, Gründker C, Hanf V. (2005). Induction of tamoxifen resistance in breast cancer cells by ELF electromagnetic fields. Biochem Biophys Res Commun, 336, 1144–1149.
   PubMed Web of Science ®Google Scholar
• Gobba F, Bargellini A, Bravo G, Scaringi M, Cauteruccio L, Borella P. (2009a). Natural killer cell activity decreases in workers occupationally exposed to extremely low frequency magnetic fields exceeding 1 microT. Int J Immunopathol Pharmacol, 22, 1059–1066.
   PubMed Web of Science ®Google Scholar
• Gobba F, Bargellini A, Scaringi M, Bravo G, Borella P. (2009b). Extremely low frequency-magnetic fields (ELF-EMF) occupational exposure and natural killer activity in peripheral blood lymphocytes. Sci Total Environ, 407, 1218–1223.
   PubMed Web of Science ®Google Scholar
• Grassi C, D’Ascenzo M, Torsello A, Martinotti G, Wolf F, Cittadini A, Azzena GB. (2004). Effects of 50 Hz electromagnetic fields on voltage-gated Ca2+ channels and their role in modulation of neuroendocrine cell proliferation and death. Cell Calcium, 35, 307–315.
   PubMed Web of Science ®Google Scholar
• Greco F, Vicent MJ. (2009). Combination therapy: Opportunities and challenges for polymer-drug conjugates as anticancer nanomedicines. Adv Drug Deliv Rev, 61, 1203–1213.
   PubMed Web of Science ®Google Scholar
• Chen C, Ma X, Zhong M, Yu Z. (2010). Extremely low-frequency electromagnetic fields exposure and female breast cancer risk: A meta-analysis based on 24,338 cases and 60,628 controls. Breast Cancer Res Treat, 123, 569–576.
   PubMed Web of Science ®Google Scholar
• Jian W, Wei Z, Zhiqiang C, Zheng F. (2009). X-ray-induced apoptosis of BEL-7402 cell line enhanced by extremely low frequency electromagnetic field in vitro. Bioelectromagnetics, 30, 163–165.
   PubMed Web of Science ®Google Scholar
• Jiménez-García MN, Arellanes-Robledo J, Aparicio-Bautista DI, Rodríguez-Segura MA, Villa-Treviño S, Godina-Nava JJ. (2010). Anti-proliferative effect of extremely low frequency electromagnetic field on preneoplastic lesions formation in the rat liver. BMC Cancer, 10, 159.
   PubMed Web of Science ®Google Scholar
• Jin M, Blank M, Goodman R. (2000). ERK1/2 phosphorylation, induced by electromagnetic fields, diminishes during neoplastic transformation. J Cell Biochem, 78, 371–379.
   PubMed Web of Science ®Google Scholar
• Kafka WA. (1998). Vorrichtung und elektrisches oder elektromagnetisches Signal zur Beeinflussung biologischer Systeme. Europäische Patentanmeldung 98119944.1 v 21.10.98.
   Google Scholar
• Kafka WA, Spodaryk K. (2003). Effects of extremely weak BEMER 3000 type pulsed electromagnetic fields on red blood cell metabolism and hemoglobin oxygen affinity, Fizoterapia, 11, 24–31.
   Google Scholar
• Kafka WA, Schütze N, Walther M. (2005). Einsatz extrem niederfrequent (BEMER typisch) gepulster schwacher elektromagnetischer Felder im Bereich der Orthopädie (Application of extreme low frequent (BEMER type) pulsed electromagnetic fields in orthopedics). Orthopädische Praxis, 41, 1, 22–24.
   Google Scholar
• de Kleijn S, Bouwens M, Verburg-van Kemenade BM, Cuppen JJ, Ferwerda G, Hermans PW. (2011). Extremely low frequency electromagnetic field exposure does not modulate toll-like receptor signaling in human peripheral blood mononuclear cells. Cytokine, 54, 43–50.
   PubMed Web of Science ®Google Scholar
• Kopecek J, Kopecková P. (2010). HPMA copolymers: Origins, early developments, present, and future. Adv Drug Deliv Rev, 62, 122–149.
   PubMed Web of Science ®Google Scholar
• Kopecek J. (2010). Biomaterials and drug delivery: Past, present, and future. Mol Pharm, 7, 922–925.
   PubMed Web of Science ®Google Scholar
• Krinick NL, Sun Y, Joyner D, Spikes JD, Straight RC, Kopecek J. (1994). A polymeric drug delivery system for the simultaneous delivery of drugs activatable by enzymes and/or light. J Biomater Sci Polym Ed, 5, 303–324.
   PubMed Web of Science ®Google Scholar
• Lammers T, Ulbrich K. (2010). HPMA copolymers: 30 years of advances. Adv Drug Deliv Rev, 62, 119–121.
   PubMed Web of Science ®Google Scholar
• Lacy-Hulbert A, Metcalfe JC, Hesketh R. (1998). Biological responses to electromagnetic fields. FASEB J, 12, 395–420.
   PubMed Web of Science ®Google Scholar
• Lange S, Viergutz T, Simkó M. (2004). Modifications in cell cycle kinetics and in expression of G1 phase-regulating proteins in human amniotic cells after exposure to electromagnetic fields and ionizing radiation. Cell Prolif, 37, 337–349.
   PubMed Web of Science ®Google Scholar
• Lin H, Blank M, Goodman R. (1999). A magnetic field-responsive domain in the human HSP70 promoter. J Cell Biochem, 75, 170–176.
   PubMed Web of Science ®Google Scholar
• Liang Y, Hannan CJJr, Chang BK, Schoenlein PV. (1997). Enhanced potency of daunorubicin against multidrug resistant subline KB-ChR-8-5-11 by a pulsed magnetic field. Anticancer Res, 17, 2083–2088.
   PubMed Web of Science ®Google Scholar
• Laqué-Rupérez E, Ruiz-Gómez MJ, de la Peña L, Gil L, Martínez-Morillo M. (2003). Methotrexate cytotoxicity on MCF-7 breast cancer cells is not altered by exposure to 25 Hz, 1.5 mT magnetic field and iron (III) chloride hexahydrate. Bioelectrochemistry, 60, 81–86.
   PubMed Web of Science ®Google Scholar
• Lammers T. (2010). Improving the efficacy of combined modality anticancer therapy using HPMA copolymer-based nanomedicine formulations. Adv Drug Deliv Rev, 62, 203–230.
   PubMed Web of Science ®Google Scholar
• Murthy SN. (1999). Magnetophoresis: An approach to enhance transdermal drug diffusion. Pharmazie, 54, 377–379.
   PubMed Web of Science ®Google Scholar
• Orel VE, Kudryavets YI, Satz S, Bezdenezhnih NA, Danko ML, Khranovskaya NN, Romanov AV, Dzyatkovskaya NN, Burlaka AP. (2005). Mechanochemically activated doxorubicin nanoparticles in combination with 40 MHz frequency irradiation on A-549 lung carcinoma cells. Drug Deliv, 12, 171–178.
   PubMed Web of Science ®Google Scholar
• Phillips JL, Singh NP, Lai H. (2009). Electromagnetic fields and DNA damage. Pathophysiology, 16, 79–88.
   PubMedGoogle Scholar
• Plotnikov A, Fishman D, Tichler T, Korenstein R, Keisari Y. (2004). Low electric field enhanced chemotherapy can cure mice with CT-26 colon carcinoma and induce anti-tumour immunity. Clin Exp Immunol, 138, 410–416.
   PubMed Web of Science ®Google Scholar
• Pollán M, Gustavsson P, Floderus B. (2001). Breast cancer, occupation, and exposure to electromagnetic fields among Swedish men. Am J Ind Med, 39, 276–285.
   PubMed Web of Science ®Google Scholar
• Porock D, Gentry J. (2002). Re: Night shift work, light at night, and risk of breast cancer. J Natl Cancer Inst, 94, 530–1; author reply 533.
   PubMedGoogle Scholar
• Prestwich RJ, Errington F, Hatfield P, Merrick AE, Ilett EJ, Selby PJ, Melcher AA. (2008). The immune system–Is it relevant to cancer development, progression and treatment? Clin Oncol, 20, 101–112.
   PubMed Web of Science ®Google Scholar
• Rannug A, Holmberg B, Ekström T, Mild KH. (1993). Rat liver foci study on coexposure with 50 Hz magnetic fields and known carcinogens. Bioelectromagnetics, 14, 17–27.
   PubMed Web of Science ®Google Scholar
• Rossi E, Corsetti MT, Sukkar S, Poggi C. (2007). Extremely low frequency electromagnetic fields prevent chemotherapy induced myelotoxicity. Electromagn Biol Med, 26, 277–281.
   PubMed Web of Science ®Google Scholar
• Richard D, Lange S, Viergutz T, Kriehuber R, Weiss DG, Myrtill S. (2002). Influence of 50 Hz electromagnetic fields in combination with a tumour promoting phorbol ester on protein kinase C and cell cycle in human cells. Mol Cell Biochem, 232, 133–141.
   PubMed Web of Science ®Google Scholar
• Ronchetto F, Barone D, Cintorino M, Berardelli M, Lissolo S, Orlassino R, Ossola P, Tofani S. (2004). Extremely low frequency-modulated static magnetic fields to treat cancer: A pilot study on patients with advanced neoplasm to assess safety and acute toxicity. Bioelectromagnetics, 25, 563–571.
   PubMed Web of Science ®Google Scholar
• Ruiz-Gómez MJ, Martínez-Morillo M. (2009). Electromagnetic fields and the induction of DNA strand breaks. Electromagn Biol Med, 28, 201–214.
   PubMed Web of Science ®Google Scholar
• Ríhová B, Strohalm J, Kubácková K, Jelínková M, Hovorka O, Kovár M, Plocová D, Sírová M, St’astný M, Rozprimová L, Ulbrich K. (2002). Acquired and specific immunological mechanisms co-responsible for efficacy of polymer-bound drugs. J Control Release, 78, 97–114.
   PubMed Web of Science ®Google Scholar
• Ríhová B, Kovár M. (2010). Immunogenicity and immunomodulatory properties of HPMA-based polymers. Adv Drug Deliv Rev, 62, 184–191.
   PubMed Web of Science ®Google Scholar
• Scarfí MR, Sannino A, Perrotta A, Sarti M, Mesirca P, Bersani F. (2005). Evaluation of genotoxic effects in human fibroblasts after intermittent exposure to 50 Hz electromagnetic fields: A confirmatory study. Radiat Res, 164, 270–276.
   PubMed Web of Science ®Google Scholar
• Scott A, Dana KM, Stewens RY. (2002). Residential magnetic fields and risk of breast cancer. Am J Epidemiol, 155, 446–454.
   PubMed Web of Science ®Google Scholar
• Sommer AM, Streckert J, Bitz AK, Hansen VW, Lerchl A. (2004). No effects of GSM-modulated 900 MHz electromagnetic fields on survival rate and spontaneous development of lymphoma in female AKR/J mice. BMC Cancer, 4, 77.
   PubMed Web of Science ®Google Scholar
• Sommer AM, Bitz AK, Streckert J, Hansen VW, Lerchl A. (2007). Lymphoma development in mice chronically exposed to UMTS-modulated radiofrequency electromagnetic fields. Radiat Res, 168, 72–80.
   PubMed Web of Science ®Google Scholar
• Sirova M, Mrkvan T, Etrych T, Chytil P, Rossmann P, Ibrahimova M, Kovar L, Ulbrich K, Rihova B. (2010). Preclinical evaluation of linear HPMA-doxorubicin conjugates with pH-sensitive drug release: Efficacy, safety, and immunomodulating activity in murine model. Pharm Res, 27, 200–208.
   PubMed Web of Science ®Google Scholar
• Tofani S, Cintorino M, Barone D, Berardelli M, De Santi MM, Ferrara A, Orlassino R, Ossola P, Rolfo K, Ronchetto F, Tripodi SA, Tosi P. (2002). Increased mouse survival, tumor growth inhibition and decreased immunoreactive p53 after exposure to magnetic fields. Bioelectromagnetics, 23, 230–238.
   PubMed Web of Science ®Google Scholar
• Tokalov SV, Gutzeit HO. (2004). Weak electromagnetic fields (50 Hz) elicit a stress response in human cells. Environ Res, 94, 145–151.
   PubMed Web of Science ®Google Scholar
• Trosic I, Busljeta I, Pavicic I. (2004). Blood-forming system in rats after whole-body microwave exposure; reference to the lymphocytes. Toxicol Lett, 154, 125–132.
   PubMed Web of Science ®Google Scholar
• Tuschl H, Novak W, Molla-Djafari H. (2006). In vitro effects of GSM modulated radiofrequency fields on human immune cells. Bioelectromagnetics, 27, 188–196.
   PubMed Web of Science ®Google Scholar
• Vijayalaxmi J, Prihoda TJ. (2009). Genetic damage in mammalian somatic cells exposed to extremely low frequency electro-magnetic fields: A meta-analysis of data from 87 publications (1990–2007). Int J Radiat Biol, 85, 196–213.
   PubMed Web of Science ®Google Scholar
• Weiderpass E, Vainio H, Kauppinen T, Vasama-Neuvonen K, Partanen T, Pukkala E. (2003). Occupational exposures and gastrointestinal cancers among Finnish women. J Occup Environ Med, 45, 305–310.
   PubMed Web of Science ®Google Scholar
• Williams CD, Markov MS, Hardman WE, Cameron, I.L. (2001). Therapeutic electromagnetic field effects on angiogenesis and tumor growth. Anticancer Res, 21, 3887–3891.
   PubMed Web of Science ®Google Scholar
• Zheng T, Holford T, Mayne S. (2000). Exposure to electromagnetic fields from use of electric blankets and other in-home electrical appliances and breast cancer risk. Am J Epidemiol, 151, 1103–1111.
   PubMed Web of Science ®Google Scholar